Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Alina Danu"'
Autor:
Pierre-Marie Morice, Sabine Khalife-Hachem, Marion Sassier, Véronique Lelong-Boulouard, Alina Danu, Florence Pasquier, Aline Renneville, Charles Dolladille, Jean-Baptiste Micol
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/83ffbb15c652496e88588cdc267ef6e9
Autor:
Christophe Willekens, Claude Chahine, Matteo Dragani, Sabine Khalife‐Hachem, Camille Bigenwald, Julien Rossignol, Cristina Castilla‐Llorente, Alina Danu, Jean‐Marie Michot, Veronique Saada, Sophie Cotteret, Christophe Marzac, Aline Renneville, Isabelle Plo, Sophie Broutin, Nelly Bosselut, Bruno Cassinat, Julien Lazarovici, Nathalie Droin, Stephane De Botton
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 823-826 (2023)
Externí odkaz:
https://doaj.org/article/e6046ba3ef504877ae667d93dacc1c70
Autor:
Cyril Quivoron, Anthony Tarabay, Jean-Marie Michot, Arnaud Pagès, Hélène Lecourt, Anne Aupérin, Alina Danu, Julien Lazarovici, Julien Rossignol, David Ghez, Peggy Dartigues, Véronique Vergé, Christophe Massard, Valérie Camara-Clayette, Vincent Ribrag, Clémentine Sarkozy
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/07cddb91d843474fbd7f6fa47506fa36
Autor:
Khalil Saleh, Jean‐Marie Michot, Antoine Schernberg, Julien Lazarovici, Claude Chahine, Alina Danu, Nadine Khalife‐Saleh, Julien Rossignol, David Ghez, Valentine Martin, Renaud Mazeron, Christophe Fermé, Angela Boros, Vincent Ribrag, Theodore Girinsky
Publikováno v:
Cancer Medicine, Vol 9, Iss 11, Pp 3725-3732 (2020)
Abstract Purpose In patients with indolent B‐cell non‐Hodgkin's lymphoma (B‐NHL), one course of low‐dose radiotherapy (LD‐RT) 2 × 2 Gy is emerging as new option of therapy in palliative setting. Efficacy of LD‐RT when repeated remains to
Externí odkaz:
https://doaj.org/article/e574334dd01940b1970d904119d003dd
Autor:
Jean‐Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El‐Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi‐Rouche, Patricia Martin‐Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean‐Charles Soria, Christophe Massard, Olivier A. Bernard, Peggy Dartigues, Valérie Camara‐Clayette, Vincent Ribrag
Publikováno v:
American Journal of Hematology. 98:645-657
Autor:
Fabio Andreozzi, Matteo Dragani, Cyril Quivoron, Fabien Le Bras, Tarek Assi, Alina Danu, Karim Belhadj, Julien Lazarovici, Sophie Cotteret, Olivier A. Bernard, Vincent Ribrag, Jean-Marie Michot
Publikováno v:
Cancers
Volume 15
Issue 5
Pages: 1508
Volume 15
Issue 5
Pages: 1508
Background: Despite that cytogenetic and molecular analysis of tumor cells can rapidly identify recurring molecular abnormalities, no personalized therapy is currently available in the setting of relapsed/refractory multiple myeloma (r/r MM). Methods
Autor:
Jean-Marie, Michot, Cyril, Quivoron, Clémentine, Sarkozy, Alina, Danu, Julien, Lazarovici, Khalil, Saleh, Yolla, El-Dakdouki, Vincent, Goldschmidt, Camille, Bigenwald, Matteo, Dragani, Rastislav, Bahleda, Capucine, Baldini, Julia, Arfi-Rouche, Patricia, Martin-Romano, Lambros, Tselikas, Anas, Gazzah, Antoine, Hollebecque, Ludovic, Lacroix, David, Ghez, Veronique, Vergé, Christophe, Marzac, Sophie, Cotteret, Wassila, Rahali, Jean-Charles, Soria, Christophe, Massard, Olivier A, Bernard, Peggy, Dartigues, Valérie, Camara-Clayette, Vincent, Ribrag
Publikováno v:
American journal of hematology.
Advances in molecular profiling of newly diagnosed diffuse large cell B lymphoma (DLBCL) have recently refine genetic subgroups. Genetic subgroups remain undetermined at the time of relapse or refractory (RR) disease. This study aims to decipher gene
Autor:
Julia Arfi-Rouche, Julien Rossignol, Peggy Dartigues, Vincent Ribrag, Elie El Rassy, Toni Ibrahim, Julien Lazarovici, Jean-Marie Michot, Alina Danu, David Ghez, Veronique Vergé
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e373-e380
Introduction After failure of frontline therapy, patients with relapsed/refractory diffuse large B-cell lymphoma (RR-DLBCL) that does not respond to first-line salvage chemotherapy can be recommended second-line salvage chemotherapy. The available li
Autor:
Christophe Willekens, Romain Desmaris, Peggy Dartigues, Alina Danu, Julien Lazarovici, Christophe Fermé, David Ghez, Nathalie Ibrahim, Yolla El Dakdouki, Julien Rossignol, Pamela Abdayem, Jean M. Michot, Julia Arfi Rouche, Vincent Ribrag
Publikováno v:
European Journal of Haematology. 106:574-583
Objectives To evaluate the efficacy and tolerability of an attenuated immunochemotherapy regimen based on cytarabine, etoposide and dexamethasone plus rituximab (R-mini-CYVE) in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL)
Autor:
Clémence Legoupil, Peggy Dartigues, Anna Antosikova, Christophe Willekens, François Lemare, Julien Lazarovici, Vincent Ribrag, Maxime Annereau, David Ghez, Julien Rossignol, Ariane Cerutti, Claude Chahine, Louis Bertin, Alina Danu, Jean-Marie Michot, Nadia Achab
Publikováno v:
European Journal of Haematology. 104:281-290
Background High-dose cyclophosphamide to treat solid refractory tumors demonstrated meaningful activity, while data to treat lymphoma remain scarce. This study aims to assess high-dose cyclophosphamide to treat relapsed or refractory lymphoma. Method